We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Insmed's Petition Seeks to Block Tercica's Growth Treatment Increlex
Insmed's Petition Seeks to Block Tercica's Growth Treatment Increlex
August 19, 2005
Biopharmaceutical firm Insmed has asked the FDA to reject a new drug application (NDA) for a human growth hormone treatment submitted by rival firm Tercica.